Not for diagnostic or therapeutic purposes
of Congo, Denmark, Dominican Rep., Ecuador, Ethiopia, Finland, France, Gabon, Georgia, Greece, Guyana, Hong Kong (China), India, Indonesia, Iran, Iraq, Ireland, Jamaica, Kuwait, Laos, Latvia, Lebanon, Madagascar, Malaysia, Maldives, Mexico, Morocco, Mozambique, Myanmar, Netherlands, New Zealand, Northern Ireland (United Kingdom), Niger, Nigeria, Norway, Pakistan, Palestine, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Rep San Marino, Romania, Russia, Rwanda, Senegal, Serbia, South Africa, Singapore, Slovakia, Spain, Sri Lanka, St Lucia, Sweden, Thailand, Togo, Trkiye, Ukraine, United Kingdom, United States of America, Uruguay, Venezuela and Zimbabwe.
2017 Apr 27;10:147-153
In one randomized, double-blind, placebo-controlled trial published in Diabetes, Obesity and Metabolism , researchers evaluated bremelanotide in premenopausal women with obesity